THE PROBLEMS ASSOCIATED WITH SWITCHING BRAND-NAME ANTIEPILEPTIC DRUGS TO GENERICS: A FOCUS ON TOPAMAX: A REVIEW OF LITERATURE AND A CASE REPORT
Despite the rather high efficiency of treatment for epilepsy (overall, 65–70 % of patients can achieve remission or show a considerable decrease in the frequency of seizures), there remains a challenge due to the need to use antiepileptic drugs long and regularly: therapy adherence, compliance, trea...
Saved in:
Main Authors: | K. Yu. Mukhin, O. A. Pylaeva, M. Yu. Bobylova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
ABV-press
2016-08-01
|
Series: | Русский журнал детской неврологии |
Subjects: | |
Online Access: | https://rjdn.abvpress.ru/jour/article/view/152 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
TREATMENT OF OSTEOPOROSIS: CLINICAL EXPERIENCE IN USING A GENERIC DRU
by: Nataliya Vladimirovna Toroptsova, et al.
Published: (2011-03-01) -
WHAT IS THERAPEUTIC EQUIVALENCE OF GENERIC DRUG AND HOW TO PROVE IT
by: N. P. Kutishenko, et al.
Published: (2016-01-01) -
Peculiarities of approaches to assessing the interchangeability of antiepileptic drugs
by: E. O. Zhuravleva, et al.
Published: (2018-02-01) -
The problem of choice: original drug or generic? Emphasis on rosuvastatin
by: O. A. Polyakova, et al.
Published: (2022-05-01) -
THE PROBLEM OF AGGRAVATION OF EPILEPTIC SEIZURES DURING THERAPY WITH ANTIEPILEPTIC DRUGS
by: K. Yu. Mukhin, et al.
Published: (2015-04-01)